Skip to main content
Clinical Trials/ISRCTN12741173
ISRCTN12741173
Recruiting
Not Applicable

A prospective clinical trial to evaluate the influence of surface EMG-triggered multichannel electrical stimulation on sensomotoric recovery in patients with lumbar disc herniation

Medical University of Innsbruck0 sites80 target enrollmentJanuary 15, 2017

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
umbar disc herniation
Sponsor
Medical University of Innsbruck
Enrollment
80
Status
Recruiting
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 15, 2017
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Population 1 – Patients being operatively treated
  • 1\. Patients with a lumbar disc herniation causing sensomotoric dysfunction in nerve root distribution areas L3 to S1
  • 2\. Unresponsive to non\-operative treatment for six weeks or presence of progressive symptoms or significant motor deficit or signs of nerve root compression in the face of conservative treatment
  • 3\. An indication for surgical treatment according to the guidelines of DGNC and DGOOC
  • 4\. MRI determined pathology at treatment level that correlates to primary symptoms
  • Population 2 – Patients being conservatively treated
  • 1\. Patients with a lumbar disc herniation causing sensomotoric dysfunction in nerve root distribution area L3 to S1
  • 2\. No urgent indication for surgical treatment according to the guidelines of DGNC and DGOOC
  • 3\. MRI determined pathology at treatment level that correlates to primary symptoms
  • Population 1 and 2

Exclusion Criteria

  • 1\. Cardiac pacemaker
  • 2\. Pregnancy
  • 3\. Any degenerative muscular or neurological condition that would interfere with
  • 4\. Evaluation of outcome measures including but not limited to Parkinson's disease, amytrophic lateral sclerosis, multiple sclerosis, muscular dystrophy and myelopathic diseases of different causes myelopathy
  • 5\. Unable or unwilling to comply therapeutic instructions or to comply the follow\-up visits at the study site
  • 6\. Active or chronic infection, systemic or local, systemic disease including HIV, AIDS, Hepatitis, Syphilis
  • 7\. Unable to undergo MRI
  • 8\. Active malignancy defined as a history of any invasive malignancy, except nonmelanoma skin cancer, unless the patient has been treated with curative intent and there have been no clinical signs or symptoms of the malignancy for a minimum of 5 years
  • neoplasia as the source of symptoms
  • 9\. Diabetes mellitus

Outcomes

Primary Outcomes

Not specified

Similar Trials